Eurofins Technologies said it is introducing a range of testing kits for serology-based antibody detection of patients who have been exposed to Covid-19.
- Development of assays has been spearheaded by affiliate companies Gold Standard Diagnostics, Virotech Diagnostics, NovaTec Immundiagnostica and Ingenasa
- First assays are expected to receive CE-IVD mark by April 16 and will also be submitted to the U.S. Food and Drug Administration for Emergency Use Authorization
- Eurofins Genomics’ six oligonucleotides production sites are increasing their capacity to produce probes, primers and positive controls
To view the source of this information click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.